GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » Research & Development

RBOT (Vicarious Surgical) Research & Development : $39.60 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Vicarious Surgical's Research & Development for the three months ended in Mar. 2025 was $9.42 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was $39.60 Mil.


Vicarious Surgical Research & Development Historical Data

The historical data trend for Vicarious Surgical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical Research & Development Chart

Vicarious Surgical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
9.80 22.06 43.90 47.58 40.16

Vicarious Surgical Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.97 10.92 10.80 8.46 9.42

Vicarious Surgical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $39.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicarious Surgical  (NYSE:RBOT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Vicarious Surgical Research & Development Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicarious Surgical Business Description

Traded in Other Exchanges
N/A
Address
78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
Executives
Adam David Sachs director, 10 percent owner, officer: President and CEO C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa director, 10 percent owner, officer: Chief Technology Officer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
William John Kelly officer: CFO and Treasurer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola officer: Chief Operating Officer TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
June Morris officer: CLO, General Counsel and Sec C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Khosla Ventures Opportunity Ii, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Associates Ii, Llc 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho director UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang director C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr director C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Shrikant Patnaik other: Principal C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop director C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803
Barry Stuart Greene 10 percent owner C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451